» Articles » PMID: 30420804

To Protect and to Preserve: Novel Preservation Strategies for Extracellular Vesicles

Overview
Journal Front Pharmacol
Date 2018 Nov 14
PMID 30420804
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs)-based therapeutics are based on the premise that EVs shed by stem cells exert similar therapeutic effects and these have been proposed as an alternative to cell therapies. EV-mediated delivery is an effective and efficient system of cell-to-cell communication which can confer therapeutic benefits to their target cells. EVs have been shown to promote tissue repair and regeneration in various animal models such as, wound healing, cardiac ischemia, diabetes, lung fibrosis, kidney injury, and many others. Given the unique attributes of EVs, considerable thought must be given to the preservation, formulation and cold chain strategies in order to effectively translate exciting preclinical observations to clinical and commercial success. This review summarizes current understanding around EV preservation, challenges in maintaining EV quality, and also bioengineering advances aimed at enhancing the long-term stability of EVs.

Citing Articles

Prospect of extracellular vesicles in tumor immunotherapy.

Xia W, Tan Y, Liu Y, Xie N, Zhu H Front Immunol. 2025; 16:1525052.

PMID: 40078996 PMC: 11897508. DOI: 10.3389/fimmu.2025.1525052.


Novel Carvacrol@activated Carbon Nanohybrid for Innovative Poly(lactide Acid)/Triethyl Citrate Based Sustainable Active Packaging Films.

Karabagias V, Giannakas A, Leontiou A, Karydis-Messinis A, Moschovas D, Andritsos N Polymers (Basel). 2025; 17(5).

PMID: 40076098 PMC: 11902435. DOI: 10.3390/polym17050605.


Lyophilized Small Extracellular Vesicles (sEVs) Derived from Human Adipose Stem Cells Maintain Efficacy to Promote Healing in Neuronal Injuries.

Jones B, Patel R, Wang B, Evans-Nguyen T, Patel N Biomedicines. 2025; 13(2).

PMID: 40002689 PMC: 11853053. DOI: 10.3390/biomedicines13020275.


Engineering and Monitoring the Sustained Release of Extracellular Vesicles from Hydrogels for Therapeutic Applications.

Uman S, Weingarten N, Helmers M, Iyengar A, Xu K, Worthington K Adv Nanobiomed Res. 2025; 4(11).

PMID: 39957840 PMC: 11824923. DOI: 10.1002/anbr.202400073.


Mesenchymal stem cell-derived extracellular vesicles in periodontal bone repair.

Chen M, Huang B, Su X J Mol Med (Berl). 2025; 103(2):137-156.

PMID: 39821702 DOI: 10.1007/s00109-025-02513-4.


References
1.
Roy S, Arora S, Kumari P, Ta M . A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells. Cryobiology. 2014; 68(3):467-72. DOI: 10.1016/j.cryobiol.2014.03.010. View

2.
Naslund T, Gehrmann U, Qazi K, Karlsson M, Gabrielsson S . Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity. J Immunol. 2013; 190(6):2712-9. DOI: 10.4049/jimmunol.1203082. View

3.
Panyam J, Labhasetwar V . Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003; 55(3):329-47. DOI: 10.1016/s0169-409x(02)00228-4. View

4.
Trad F, Toner M, Biggers J . Effects of cryoprotectants and ice-seeding temperature on intracellular freezing and survival of human oocytes. Hum Reprod. 1999; 14(6):1569-77. DOI: 10.1093/humrep/14.6.1569. View

5.
Xu X, Liu Y, Cui Z, Wei Y, Zhang L . Effects of osmotic and cold shock on adherent human mesenchymal stem cells during cryopreservation. J Biotechnol. 2012; 162(2-3):224-31. DOI: 10.1016/j.jbiotec.2012.09.004. View